According to the Market Statsville Group (MSG), the Global Microneedle Device Market size is expected to grow from USD 5,454.6 million in 2023 to USD 10,730.1 million by 2033, at a CAGR of 8.8% from 2024 to 2033.
A microneedle device is a medical and cosmetic tool that offers various applications, using the innovative approach of micro-scale needles to perform different functions. These devices encompass an array of extremely tiny, typically less than 1 millimeter in length, and sterile needles that are put in order on a small patch or a handheld applicator. It is manufactured from materials including polymers, metal, or silicon, and is engineered to penetrate the top layer of the skin without causing pain or damage. The microneedle devices create definite microchannels in the skin, offering an administered delivery of drugs, vaccines, or cosmetic substances. It is a minimally invasive approach as compared to traditional injections, grabbing a huge number of customers’ attention who opt for drug delivery and appropriate skincare. Microneedling has secured wide demand in the beauty industry for treating skin imperfections like acne scars and wrinkles and boosting collagen production. In addition, it has applications in medical fields for drug delivery and vaccine administration, offering a promising improvement in patient compliance and treatment potential.
Microneedle Device Market Segmental Analysis, 2024-2033
Based on application, the market is divided into dermatology, drug delivery, pain management, cancer therapy, vaccine delivery, and others. The drug delivery segment accounted for the largest market share in 2023. The increasing chronic disease incidence such as diabetes, cancer, and cardiovascular diseases, and the growing need for effective drug delivery procedures augment the segmental growth in the market. For instance, according to the Cleveland Clinic, in 2023 around 37.3 million people have diabetes in the United States, which is 11% of the country’s population. Type 2 diabetes representing 90% to 95% is the most common form of all diabetes cases. In 2023, about 537 million adults have diabetes across the world which is expected to rise to 643 million by 2030 and 783 million by 2045. The growing demand is the aging population, and so is the incidence of vascular-related conditions, driving demand for microneedle devices market.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/microneedle-device-market?utm_source=free&utm_medium=harsh
Report Scope of the Global Microneedle Device Market
This market research study categorizes the microneedle device market-based on type, material, application, and end-user area at the regional and global levels.
By Type Outlook (Sales, USD Million, 2019-2033)
- Solid
- Hollow
- Dissolving
- Coated
- Others
By Material Outlook (Sales, USD Million, 2019-2033)
- Silicon
- Metal
- Polymer
- Others
By Application Outlook (Sales, USD Million, 2019-2033)
- Dermatology
- Drug Delivery
- Pain Management
- Cancer Therapy
- Vaccine Delivery
- Others
By End-User Outlook (Sales, USD Million, 2019-2033)
- Beauty Salon
- Hospitals
- Clinic
- Others
By Region Outlook (Sales, USD Million, 2019-2033)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- UK
- Spain
- Poland
- Russia
- The Netherlands
- Norway
- Czech Republic
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Indonesia
- Malaysia
- Thailand
- Singapore
- Australia & New Zealand
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Egypt
- Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/microneedle-device-market?opt=3338&utm_source=free&utm_medium=harsh
Microneedle Device Market Key Players, 2023
The major players operating in the global microneedle device market are:
- Viol Co., Ltd.
- Candela Medical
- Cynosure
- ShenB
- Nubway
- Beijing Sanhe Beauty
- Rohrer Aesthetics
- The Lynton Group
- In Lumen
- Lutronic
- ENDYMED Medical
- Raphas
- Novartis International AG
- Becton Dickinson and Company
- B. Braun
- Nanopass technologies limited
- Termo
- Smiths Medical
- Cardinal Health
- 3M
Request For Report TOC: https://www.marketstatsville.com/table-of-content/microneedle-device-market
Recent Developments:
- In February 2023, Candela launched all-new Profound Matrix system can regenerate and build new collagen with the advanced delivering a marked improvement in overall skin appearance and texture.
- In October 2021, Cynosure, announced the cleasrance of Canadian (Health Canada) for its best-in-class Potenza radiofrequency (RF) microneedling system allows clinicians unparalleled utility and personalized treatments for patients with its one-of-a-kind Fusion Tip.
Comments
0 comment